Bernat Crosas

5PUBLICATIONS
21CO-AUTHORS
Gene and molecular therapyMolecular targetsVirologyBiologically active moleculesProteomics and intermolecular interactions (excl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 08, 2026
Proteasome dysfunction underlies HERC2-linked neurodevelopmental disorder with Angelman-like clinical features.

Joan Sala-Gaston, Laura Costa-Sastre, Manel Garcia-Diez

|Mar 28, 2026
Expanding the targeted protein degradation approach with small molecule chimeras directed to the 26S proteasome.

Mireia Casasampere, Hector Carneros, Tania Roda

|Feb 04, 2025
Induction of the Inflammasome by the SARS-CoV-2 Accessory Protein ORF9b, Abrogated by Small-Molecule ORF9b Homodimerization Inhibitors.

Erika Zodda, Mònica Pons, Natàlia DeMoya-Valenzuela

|Nov 08, 2024
Aptamer-Hytac Chimeras for Targeted Degradation of SARS-CoV-2 Spike-1.

Carme Fàbrega, Núria Gallisà-Suñé, Alice Zuin

|Aug 25, 2019
How the 26S Proteasome Degrades Ubiquitinated Proteins in the Cell.

Bernat Coll-Martínez, Bernat Crosas

Pageof 1